<DOC>
	<DOC>NCT02789358</DOC>
	<brief_summary>This study aims to validate a new dosage of cryotherapy based on time to effect in pulmonary vein ablation procedures in patients with paroxysmal atrial fibrillation.</brief_summary>
	<brief_title>A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Patients with at least 2 documented episodes of paroxysmal Atrial Fibrillation (AF) which are not responders to at least one antiarrythmic drug Previous left atrial ablation procedure or surgery left atrium diameter &gt; 50mm presence of intracardiac thrombus Left ventricular ejection fraction &lt; 40% Heart failure class IIIIV Severe valvulopathies Acute coronary syndrome or cardiac surgery within the previous 3 months of enrollment Transient ischemic attack/stroke within the previous 6 months of enrollment life expectancy less than 1 year Any contraindication to the procedure according to the current clinical practice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cryotherapy</keyword>
</DOC>